CHIKV E2 Specific Neutra™ Antibody Products
Product listAccelerate Your Research and Development!
Are you currently facing challenges with viral research, including the need for highly specific detection tools, a lack of reliable research reagents for Chikungunya virus, or difficulties in developing effective diagnostic assays? Creative Biolabs' CHIKV E2 Specific Antibody Products help you accelerate your research into viral pathogenesis and streamline the development of robust diagnostic and therapeutic solutions through advanced recombinant antibody technology and high-specificity characterization.
Contact our team to get an inquiry now!
Introduction of CHIKV E2
Chikungunya virus (CHIKV) is an arthropod-borne pathogen transmitted to humans by mosquitos, leading to a disease characterized by high fever, debilitating joint pain, and rash. As an alphavirus, CHIKV is an enveloped, single-stranded positive-sense RNA virus. Its surface is adorned with trimeric spikes composed of two key glycoproteins, E1 and E2. The E2 glycoprotein is a structural protein composed of three domains: A, B, and C. It plays a critical role in the viral life cycle by mediating the attachment of the virus to host cells. This attachment is a crucial first step for viral entry and infection. Due to its essential function in cell attachment and its exposure on the viral surface, the E2 protein is a primary target for the host's immune system, making it a highly significant antigen for vaccine and therapeutic development.
Fig.1 Structure of Chikungunya virus (CHIKV) and envelope glycoproteins.1
Our Anti-CHIKV E2 Antibody Products
Antibodies targeting the CHIKV E2 protein are instrumental for a wide range of applications in viral research, diagnostics, and therapeutics. In research, they are essential tools for:
- Immunodetection: Used in assays like ELISA, Western Blotting, and Immunofluorescence to detect and quantify the presence of the E2 protein in cell cultures or biological samples.
- Neutralization Studies: Anti-E2 antibodies can block the interaction between the virus and its host cell receptors, thereby neutralizing the virus and preventing infection. This application is fundamental for assessing the efficacy of potential vaccine candidates and therapeutic antibodies.
- Flow Cytometry: Antibodies are utilized to analyze virus-infected cells, providing insights into viral load, kinetics of infection, and the cellular tropism of the virus.
In a broader context, the development of highly specific anti-E2 antibodies is a cornerstone of therapeutic and diagnostic strategies. They can serve as key components in rapid diagnostic tests, providing a reliable method for distinguishing CHIKV infections from those caused by other arboviruses like Dengue or Zika. Furthermore, neutralizing anti-E2 monoclonal antibodies have shown promise in preclinical studies by protecting against viral infection and mitigating disease pathology in animal models, demonstrating their potential as therapeutic interventions for Chikungunya fever.
Why Choose Us?
Choosing Creative Biolabs for your CHIKV E2 antibody needs means partnering with a leader in biotechnology and scientific innovation. Our products are developed with the highest standards of quality and scientific rigor, ensuring superior performance and reliability.
- High Specificity and Sensitivity: Our antibodies are engineered to bind with high affinity to specific epitopes on the CHIKV E2 protein, minimizing cross-reactivity and delivering clean, unambiguous results.
- Robust Quality Control: Every product undergoes rigorous quality control testing to ensure lot-to-lot consistency and optimal performance in a variety of applications.
- Broad Application Range: Whether your project involves basic research into viral mechanisms, development of diagnostic kits, or exploring therapeutic applications, our antibodies are optimized for a diverse range of immunoassay formats.
- Reliable Performance: Our antibodies have demonstrated reliable performance across various research projects, enabling accurate data generation. We leverage advanced manufacturing processes to ensure the stability and longevity of our products.
Creative Biolabs' CHIKV E2 Specific Antibody Products provide researchers and developers with a powerful and reliable tool for overcoming the challenges of viral research and diagnostics. From foundational studies of viral pathogenesis to the development of cutting-edge therapeutic and diagnostic solutions, our high-quality antibodies are a cornerstone for scientific success.
Access the Creative Biolabs Edge – Request Your Quote Now
FAQs
Q: How can specific epitopes on the E2 protein ensure broad reactivity across different Chikungunya virus strains?
A: The E2 protein contains both variable and conserved regions. Antibody development focuses on identifying and targeting epitopes within these highly conserved domains. This strategic approach ensures the antibodies maintain robust binding affinity and function, enabling broad detection and neutralization capabilities against multiple viral strains.
Q: Are anti-CHIKV E2 antibodies suitable for both in vitro and in vivo studies?
A: Yes, antibodies against the E2 protein are highly versatile. They are validated for use in standard in vitro immunoassays like ELISA and flow cytometry for detection and quantification. Additionally, due to the E2 protein's role in viral pathogenesis, neutralizing antibodies can be employed in in vivo models to study infection mechanisms and evaluate potential therapeutic efficacy.
Q: How does an antibody-based approach to CHIKV detection compare to nucleic acid-based methods like RT-PCR?
A: While RT-PCR is essential for detecting viral RNA, an antibody-based approach provides complementary information by directly detecting the viral protein itself. This is particularly valuable for studying protein expression levels, viral assembly, and for diagnostic applications where protein-level detection may be required. Antibody-based assays are often faster and more adaptable for high-throughput screening.
Q: What is the mechanism by which anti-E2 antibodies can neutralize the Chikungunya virus?
A: The E2 protein is responsible for the crucial initial step of viral attachment to host cell receptors. Neutralizing antibodies bind to specific sites on the E2 protein, sterically hindering the virus from binding to its target cell. This effectively blocks viral entry and prevents the initiation of infection, offering a powerful mechanism for therapeutic intervention.
REFERENCE
- Jin, Jing, and Graham Simmons. "Antiviral Functions of Monoclonal Antibodies against Chikungunya Virus." Viruses vol. 11,4 305. 28 Mar. 2019, Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/v11040305
